Daniel Peterson, MD
Neurological Surgery · Austin, TXNPI 1518027366
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $397,912 of the $442,287 with a category attached, or 90.0%. Alafair Biosciences, Inc. accounts for 87.6% of it on its own, with 28 other manufacturers making up the rest. Among neurological surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 905 payments — averaging $488.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alafair Biosciences, Inc.$387K
- Retropsoas Technologies, LLC$9K
- Abbott$9K
- Cerapedics Inc.$8K
- Biotronik Inc.$6K
- 4web, Inc.$6K
- plus $17K from 23 others
Across 51 payments — averaging $2298.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cerapedics Inc.$46K
- Surgalign Spine Technologies, Inc.$34K
- Bioventus LLC$31K
- Heron Therapeutics, Inc.$6K
Across 21 payments — averaging $250,775 each. An ownership or investment interest held by the physician or an immediate family member.
- Alafair Biosciences, Inc.$5.3M
What the payments were for
- Consulting fees$397,91290%
- Speaking & faculty fees$2320%
- Travel & lodging$14,0413%
- Food & beverage$29,6097%
- Education$180%
- Gifts$3500%
- Entertainment$1250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alafair Biosciences, Inc. | 170 | $387,288 |
| Retropsoas Technologies, LLC | 12 | $9,433 |
| Abbott | 327 | $9,075 |
| Cerapedics Inc. | 8 | $7,747 |
| Biotronik Inc. | 4 | $6,237 |
| 4web, Inc. | 12 | $5,966 |
| Biotronik NRO, Inc. | 4 | $5,425 |
| Boston Scientific | 250 | $4,852 |
| Spinal Elements, Inc. | 17 | $1,259 |
| 7d Surgical Inc. | 8 | $1,057 |
| Globus Medical(2 entities) | 20 | $792 |
| Nevro Corp. | 10 | $763 |
| Medtronic | 22 | $468 |
| Si-bone, Inc. | 7 | $323 |
| Centinel Spine, LLC | 5 | $301 |
| Acutus Medical, Inc. | 2 | $289 |
| Spineart USA Inc | 2 | $177 |
| Painteq LLC | 2 | $136 |
| Surgalign Spine Technologies, Inc. | 4 | $123 |
| Johnson & Johnson | 2 | $123 |
| Orthofix Medical, Inc. | 3 | $88 |
| Wenzel Spine, Inc. | 1 | $81 |
| Redhill Biopharma Inc. | 3 | $60 |
| Theradaptive, Inc. | 1 | $57 |
| Davol Inc. | 1 | $55 |
| Relievant Medsystems, Inc. | 2 | $53 |
| Bioventus LLC | 1 | $24 |
| Intrinsic Therapeutics | 4 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VersaWrap$383,594
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$7,400
- SPINE TRUSS SYSTEM$5,561
- Prospera$5,394
- PROCLAIM$2,634
- IonicRF Generator$750
- VersaWrap Tendon Protector$576
- Senza$536
- Medical Devices$505
- Medical Device$406
- GENERAL PAIN MANAGEMENT$299
- Proclaim IPG$294
- Omnia$266
- iFuse Implant$147
- OCTRODE$136
- i-FACTOR Putty$122
- Proclaim Family of SCS IPGs$119
- TRIALTIS$108
How this compares
$442,287 in reported general payments places this provider in the 95th percentile of 582 neurological surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MovantikNaloxegol Oxalate | 21 | $8,501 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 242 | $2,304 |
| Methocarbamol | 190 | $900 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 54 | $690 |
| Gabapentin | 52 | $507 |
| Meloxicam | 30 | $186 |
| Tramadol Hcl | 50 | $137 |
| Methylprednisolone | 25 | $103 |
| Pregabalin | 13 | $103 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Redhill Biopharma Inc.Movantik | $60 | $8,50121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 582 neurological surgery providers in Texas.
Other neurological surgery in Austin
- Douglas FoxAustin$948K
- John StokesAustin$522K
- Thomas LoftusAustin$379K
- Jon WillieAustin$137K
- Koijan KainthThe Woodlands$1.3M
- Luis DuarteSan Angelo$1.2M
- Richard MeyratDallas$883K
- Adam LewisCorpus Christi$792K
- Arnold VardimanSan Antonio$687K
- Andrew RoeserHouston$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.